Description
Recombinant Enterokinase (rEK) is a highly purified recombinant fragment of bovine enterokinase light chain. Its amino acid sequence is identical to that of the native bovine enterokinase light chain, providing the same substrate specificity as naturally extracted enterokinase. The cleavage site is Asp-Asp-Asp-Asp-Lys (DDDDK), which enables removal of fusion tags located at the N-terminus of recombinant proteins, ensuring accurate N-terminal sequence of the target protein. Additionally, recombinant enterokinase exhibits higher catalytic activity compared to its natural counterpart.
GMP-grade Recombinant Enterokinase (with His-tag) is a high-purity, high-activity, and highly specific bovine enterokinase produced via secretion expression in Pichia pastoris. Manufactured under GMP-compliant processes, this enzyme effectively cleaves fusion proteins over a broad pH range (4.5–9.5) and a wide temperature range, and retains partial activity even in the presence of various detergents and denaturing agents. The enzyme contains a His-tag, allowing easy removal after the cleavage reaction using a Ni²⁺ affinity column, significantly simplifying downstream purification procedures.
Features
High Specificity: A specific protease that cleaves at the carboxyl terminus of lysine following four aspartic acid residues: Asp-Asp-Asp-Asp-Lys (DDDDK).
High Purity: Free from other proteases; no non-specific cleavage observed.
Non-animal Origin: Recombinantly produced, free from exogenous viral contamination; no animal-derived materials used during production.
Consistent Quality: Batch production ensures stable and continuous supply with minimal lot-to-lot variation.
High Production Capacity: YEASEN possesses fermentation systems ranging from 5 L to 1500 L, capable of meeting diverse customer demands across different development and production stages.
Multiple Grade Options: R&D Grade (Cat# 20395ES) and GMP Grade (Cat# 20396ES). GMP-grade products are manufactured under ISO 13485 quality management system and are supported with comprehensive quality documentation.
Specifications
Source |
Recombinantly expressed in Pichia pastoris |
Molecular Weight |
Theoretical: 22.7 kDa <br>Note: Due to glycosylation in Pichia expression, the apparent molecular weight on SDS-PAGE is approximately 40 kDa. |
Appearance |
Sterile liquid |
Storage Buffer |
50 mM Tris-HCl, 250 mM NaCl, 2 mM CaCl₂, 50% Glycerol, pH 8.0 |
Enzyme Concentration |
5 U/μL |
Purity |
≥95% |
Endotoxin |
<1 EU/μg |
Host Protein Residue |
≤0.01% |
Host DNA Residue |
≤10 ng/mg |
Activity Definition |
One unit is defined as the amount of enzyme required to cleave 95% of 50 μg of a fusion protein containing the enterokinase recognition site (positive substrate, ~64.6 kDa, Cat# 20391ES) in 12–16 hours at 25°C under the following buffer conditions: 20 mM Tris-HCl, 50 mM NaCl, 2 mM CaCl₂, pH 8.0. |
[Note]: Cleavage efficiency may vary depending on the substrate. Smaller proteins are generally cleaved more efficiently. The enzyme activity is defined using a ~64.6 kDa substrate. For small peptide substrates, cleavage efficiency may reach up to 1 U per 500 μg of substrate.
Components
Components No. |
Name |
20396ES90 |
20396ES92 |
20396ES94 |
20396 |
UCF.METM Recombinant Enterokinase GMP-grade(His Tag) |
5000 U |
100 KU |
1 MU(1000 KU) |
Shipping and Storage
This product should be stored at -25~-15℃ for 2 years.
Application
Removal of N-terminal fusion tags from recombinant proteins to ensure accurate protein sequences.
Widely used in the biopharmaceutical field, including the production of GLP-1 analog peptide drugs.
Figures
1. High Specificity
Figure 1. Yeasen Enterokinase (Cat#20396ES) demonstrates superior cleavage performance compared to Supplier N*.
2. Strong Stability
Figure 2. Stability of Yeasen enterokinase (Cat#20396ES) under repeated freeze–thaw cycles and accelerated storage conditions. Enzyme activity remained stable with no significant loss.
Two randomly selected batches of Yeasen enterokinase (Cat#20396ES) were tested. After 10 and 20 freeze–thaw cycles, enzyme activity showed no significant change compared with the initial activity. Similarly, storage at 25 °C for 7, 16, and 32 days, and at 37 °C for 7 and 14 days, showed no significant reduction in activity.
Documents:
Safety Data Sheet
Manuals
Paiement et sécurité
Vos informations de paiement sont traitées en toute sécurité. Nous ne stockons pas les détails de la carte de crédit ni accès aux informations de votre carte de crédit.
Enquête
Vous pouvez aussi aimer
FAQ
Le produit est destiné à des fins de recherche uniquement et n'est pas destiné à un usage thérapeutique ou diagnostique chez l'homme ou l'animal. Les produits et le contenu sont protégés par des brevets, des marques déposées et des droits d'auteur appartenant à Yeasen Biotechnology. Les symboles de marque indiquent le pays d'origine, pas nécessairement l'enregistrement dans toutes les régions.
Certaines applications peuvent nécessiter des droits de propriété intellectuelle tiers supplémentaires.
Yeasen se consacre à la science éthique, estimant que nos recherches doivent répondre à des questions cruciales tout en garantissant la sécurité et les normes éthiques.